Royalty Pharma plc Class A

Royalty Pharma plc Class A is the world's largest buyer of biopharmaceutical royalties and a leading provider of capital to the life sciences industry. The company acquires royalty interests in innovative medicines and therapies developed by pharmaceutical and biotechnology companies, research institutions, and academic organizations. Through its unique business model, Royalty Pharma provides funding that supports scientific research, drug development, and commercialization efforts. The company's diversified portfolio includes royalties from numerous blockbuster medicines across a wide range of therapeutic areas, enabling participation in the long-term growth of the healthcare sector. Headquartered in New York City, Royalty Pharma is dedicated to accelerating medical innovation and improving patient outcomes worldwide.